Loading quotes...
Forecast
The analysts' average price target is €7.90 (+41.83%). The median is €7.16 (+28.55%).
| Buy |
Â
15 |
| Hold |
Â
27 |
| Sell |
Â
0 |
News Go to news feed
BetterHelp and Sophia Bush launch The Permission Project to address women's mental health
BetterHelp launched The Permission Project, a therapist-developed initiative partnered with Sophia Bush that provides a Rewrite Guide, 10,000 hours of free therapy and a $100,000 investment in therapists focused on women’s mental health. The program is based on research identifying social tensions—like being ambitious but likeable—that correlate with rising anxiety and depression among women and offers actionable steps to counter them. Bush, who contributed to the project, emphasizes systemic causes of women's unrecognized labor and the need for cultural change alongside individual support. » More on forbes.com
Teladoc Health appoints Michael Grasher as chief financial officer
Teladoc Health has appointed Michael Grasher as CFO, effective immediately. Grasher has more than 30 years of experience in the insurance and financial services sector, including over 12 years in CFO roles at companies such as IFG Companies, Fortegra and AMERISAFE, and he also spent many years in equity research. » More on de.investing.com
Teladoc Health appoints Mark V. Anquillare to the board of directors
Teladoc Health has appointed Mark V. Anquillare, former president and COO of Verisk Analytics, to its board of directors. He will serve on the audit and compensation committees and brings more than 30 years of experience in finance and leadership roles, including overseeing Verisk’s 2009 IPO. Anquillare also sits on several other boards; Teladoc Health provides virtual healthcare services through partnerships with insurers, employers and health systems. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 531.8M | 0.81% |
| Gross profit | 545.08M | 45.56% |
| Net profit | -34.09M | 23.03% |
| EBITDA | 54.38M | 31.20% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €1.03B |
Number of shares | 181.68M |
52-week high/low | €8.85 - €3.94 |
| Dividends | No |
Beta | 2.14 |
P/E ratio | -6.40 |
PEG ratio | -0.39 |
P/B ratio | 0.87 |
P/S ratio | 0.46 |
Company profile
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
| Name | Teladoc Health |
| CEO | Charles Divita |
| Headquarters | New York,
ny USA |
| Website | |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| IPO | 06/30/2015 |
| Employees | 5,124 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NYSE | TDOC |
London Stock Exchange | 0LDR.L |
XETRA | 4LL.F |
Frankfurt | 4LL.F |
DĂĽsseldorf | 4LL.DU |
London | 0LDR.L |
SIX | 4LL.SW |
MĂĽnchen | 4LL.MU |